»çÁøÁ¦°ø=Çѱ¹¾àÁ¦ÇÐȸ |
»çÁøÁ¦°ø=Çѱ¹¾àÁ¦ÇÐȸ |
µÎ ¹ø° ¼¼¼ÇÀÇ ¡âPreclinical and clinical aspects of various SN-38 nanomedicine (¹Ú¿µÈ¯ ´ëÇ¥, ¢ß¿¡½º¿£¹ÙÀÌ¿À»çÀ̾ð½º) ¡âLessons learned from drug interactions studies in drug development (äÀ±Áö ±³¼ö, ¿ì¼®´ë ¾àÇдëÇÐ) ¡âDevelopment of RNA structures for the cancer therapeutic vaccine system (À̱Ը® ±³¼ö, °æ»ó´ë ¾àÇдëÇÐ) ¡âCationic polymer development for mRNA delivery and their application for CRISPR-Cas technology (±èÇöÁø ±³¼ö, ÀÎÇÏ´ë »ý¸í°øÇаú) µîÀÇ ÁÖÁ¦ ¹ßÇ¥¿¡ ÀÌ¾î ¼¼ ¹ø° ¼¼¼ÇÀº ¡âInnovation of microsphere-based drug delivery platform (±èÁÖÈñ ´ëÇ¥, ¢ßÀκ¥Æ¼Áö·¦) ¡âIntroducing Grabody B: ABL Bio's BBB shuttling platform technology and its application (¾È¼º¿ø ¼ö¼®¿¬±¸¿ø, ¿¡À̺ñ¿¤¹ÙÀÌ¿À) ¡âDevelopment of microneedle array patch and its medical applications (ÃÖ¼º¿À ¿¬±¸¼ÒÀå, ¢ßÄõµå¸Þµð½¼)ÀÇ ÁÖÁ¦ ¹ßÇ¥·Î ÁøÇàµÆ´Ù.
Çѱ¹¾àÁ¦ÇÐȸ ±Ç¿À½Â ȸÀåÀº "Äڷγª19 Ææ´õ¹ÍÀÌ Ã˹ßÇÑ ºñ´ë¸é »çȸ¹®ÈÀÇ ¿©ÆÄ·Î DNA(Data, Network, AI) ±â¼úÀÌ ºü¸£°Ô Áøº¸ÇÏ°í ÀÖÀ¸¸ç, ÀÌ¿Í ´õºÒ¾î Á¦¾à, º¸°ÇÀÇ·á ¹× ÇコÄÉ¾î ºÐ¾ß ±â¼úÀÇ ±Û·Î¹ú ȯ°æµµ ±ÞÁøÀûÀ¸·Î º¯ÇÏ°í ÀÖ´Ù. ÀÌ·¯ÇÑ ±Û·Î¹ú ±â¼úÀÇ È¯°æ º¯È¿¡ ºÎÀÀÇÏ°í ¾àÁ¦ÇÐ ºÐ¾ßÀÇ ÃֽŠÁö½Ä°ú Á¤º¸ Á¦°ø¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö´Â »óȲ¿¡¼ Çѱ¹¾àÁ¦ÇÐȸ´Â ½Å¾à°³¹ß Á¤º¸±³È¯ ¹× Àü·« ¼ö¸³¿¡ µµ¿òÀÌ µÇ°íÀÚ 2021 °úÇÐÀÇ ´Þ ±â³ä ½ÉÆ÷Áö¾öÀ» °³ÃÖÇß´Ù"¸ç ƯÈ÷ "À̹ø ½ÉÆ÷Áö¾öÀÌ Ç×ü ¹× ¹é½Å µîÀÇ ´Ü¹éÁúÄ¡·áÁ¦ °³¹ß ¹× Çõ½Å°³·® ¹ÙÀÌ¿ÀÀǾàÇ°ÀÇ Á¦Á¶, »ý»ê, Ç°Áú, ÀÎÇã°¡ ÀÚ·á °³¹ß¿¡ µµ¿òÀÌ µÇ±â¸¦ ¹Ù¶ó¸ç, º» ½ÉÆ÷Áö¾ö¿¡ °ü·Ã ½Ç¹«ÀÚ ¹× ¿¬±¸Àڵ鲲¼ ¸¹ÀÌ Âü¼®ÇÏ¿© ÇмúÀû ±³·ù¿Í ³×Æ®¿öÅ·ÀÇ ÀåÀÌ µÇ¾ú±â¸¦ Èñ¸ÁÇÑ´Ù"°í ¸»Çß´Ù.